NovoCure (NVCR) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $14.07, -2.36% vs the prior close of $14.41.
- Volume 1.29M shares, 1.0x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NVCR dips 2.4% to $14.07. Closed at $14.07, -2.36% vs the prior close of $14.41. Day range $13.88–$14.41, opened at $14.41.
NVCR daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — NVCR dips 2.4% to $14.07
- Closed at $14.07, -2.36% vs the prior close of $14.41. Day range $13.88–$14.41, opened at $14.41.
- Volume was 1.29M shares, 1.0x its 50-day average of 1.27M.
- Price is -14.0% vs its 50-day average ($16.36) and -4.8% vs its 200-day average ($14.79).
- 52-week range $9.82–$21.45; today's close sits at 37% of that range, 34.4% below the 52-week high.
Oct 15, 2026 — NVCR jumps 4.1% to $14.41
- Closed at $14.41, +4.12% vs the prior close of $13.84. Day range $13.84–$14.46, opened at $13.85.
- Volume was 1.81M shares, 1.4x its 50-day average of 1.26M.
- Price is -12.1% vs its 50-day average ($16.39) and -2.5% vs its 200-day average ($14.78).
- 52-week range $9.82–$21.45; today's close sits at 39% of that range, 32.8% below the 52-week high.
Oct 14, 2026 — NVCR slides 3.2% to $13.84, a 3-month low
- Closed at $13.84, -3.22% vs the prior close of $14.30. Day range $13.76–$14.26, opened at $14.15.
- Volume was 1.19M shares, 0.9x its 50-day average of 1.27M.
- Price is -15.7% vs its 50-day average ($16.43) and -6.3% vs its 200-day average ($14.78).
- 52-week range $9.82–$21.45; today's close sits at 35% of that range, 35.5% below the 52-week high.
Oct 13, 2026 — NVCR dips 2.9% to $14.30
- Closed at $14.30, -2.85% vs the prior close of $14.72. Day range $14.29–$14.75, opened at $14.66.
- Volume was 772.60K shares, 0.6x its 50-day average of 1.29M — lighter than usual.
- Price is -13.2% vs its 50-day average ($16.48) and -3.2% vs its 200-day average ($14.77).
- 52-week range $9.82–$21.45; today's close sits at 39% of that range, 33.3% below the 52-week high.
Oct 12, 2026 — NVCR rises 1.0% to $14.72
- Closed at $14.72, +0.96% vs the prior close of $14.58. Day range $14.26–$14.76, opened at $14.54.
- Volume was 782.00K shares, 0.6x its 50-day average of 1.30M.
- Price is -10.8% vs its 50-day average ($16.50) and -0.3% vs its 200-day average ($14.77).
- 52-week range $9.82–$21.45; today's close sits at 42% of that range, 31.4% below the 52-week high.
Oct 9, 2026 — NVCR rises 2.5% to $14.58
- Closed at $14.58, +2.53% vs the prior close of $14.22. Day range $14.14–$14.78, opened at $14.17.
- Volume was 1.02M shares, 0.8x its 50-day average of 1.31M.
- Price is -11.6% vs its 50-day average ($16.50) and -1.2% vs its 200-day average ($14.76).
- 52-week range $9.82–$21.45; today's close sits at 41% of that range, 32.0% below the 52-week high.
Oct 8, 2026 — NVCR slides 3.0% to $14.22, a 3-month low on 2.3x normal volume
- Closed at $14.22, -3.00% vs the prior close of $14.66. Day range $13.82–$14.59, opened at $14.59.
- Volume was 2.96M shares, 2.3x its 50-day average of 1.28M — unusually heavy trading.
- Price is -13.9% vs its 50-day average ($16.51) and -3.6% vs its 200-day average ($14.76).
- 52-week range $9.82–$21.45; today's close sits at 38% of that range, 33.7% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — NVCR dips 2.1% to $14.66, a 3-month low on 2.8x normal volume
- Closed at $14.66, -2.07% vs the prior close of $14.97. Day range $14.59–$15.12, opened at $14.84.
- Volume was 3.51M shares, 2.8x its 50-day average of 1.23M — unusually heavy trading.
- Price is -11.3% vs its 50-day average ($16.53) and -0.6% vs its 200-day average ($14.75).
- 52-week range $9.82–$21.45; today's close sits at 42% of that range, 31.7% below the 52-week high.
Oct 6, 2026 — NVCR dips 1.5% to $14.97
- Closed at $14.97, -1.51% vs the prior close of $15.20. Day range $14.90–$15.88, opened at $15.27.
- Volume was 1.76M shares, 1.4x its 50-day average of 1.23M.
- Price is -9.6% vs its 50-day average ($16.56) and +1.6% vs its 200-day average ($14.74).
- 52-week range $9.82–$21.45; today's close sits at 44% of that range, 30.2% below the 52-week high.
Oct 5, 2026 — NVCR rises 1.7% to $15.20
- Closed at $15.20, +1.74% vs the prior close of $14.94. Day range $14.56–$15.30, opened at $14.82.
- Volume was 1.78M shares, 1.4x its 50-day average of 1.28M.
- Price is -8.5% vs its 50-day average ($16.60) and +3.2% vs its 200-day average ($14.73).
- 52-week range $9.82–$21.45; today's close sits at 46% of that range, 29.1% below the 52-week high.
Oct 2, 2026 — NVCR slides 6.2% to $14.94, a 1-month low, 3 down days in a row
- Closed at $14.94, -6.16% vs the prior close of $15.92. Day range $14.91–$16.24, opened at $16.24.
- Volume was 1.70M shares, 1.2x its 50-day average of 1.42M.
- Price is -10.3% vs its 50-day average ($16.65) and +1.5% vs its 200-day average ($14.71).
- 52-week range $9.82–$21.45; today's close sits at 44% of that range, 30.4% below the 52-week high.
- That makes 3 straight losses.
NVCR latest news & SEC filings
Every SEC filing by or about NVCR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 23, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jul 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 23, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $183.58M (prior year $158.81M) (+15.6% vs Jun 30, 2025)
- Net income: -$15.66M (prior year -$40.14M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.13 (prior year -$0.36) (loss narrowed vs Jun 30, 2025)
Jul 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade NVCR
- Last results release: Jul 23, 2026 (8-K Item 2.02). Previous ones: Apr 30, 2026, Feb 26, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Oct 22, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.94% (largest 6.2%).
- Liquidity: about 1.40M shares (≈$19.63M) trade per day on average.
- 52-week position: $14.07 vs a range of $9.82–$21.45 (37% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Frank X Leonard sold 34,273 shares on Jun 4, 2026.
- Latest filings: 8-K Oct 1, 2026; 8-K Sep 9, 2026; 8-K Sep 1, 2026.
- Share count: 116.45M shares outstanding (Jul 17, 2026), +4.2% vs a year earlier.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
NVCR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 14.41 | 14.41 | 13.88 | 14.07 | 1.29M |
| Oct 15, 2026 | 13.85 | 14.46 | 13.84 | 14.41 | 1.81M |
| Oct 14, 2026 | 14.15 | 14.26 | 13.76 | 13.84 | 1.19M |
| Oct 13, 2026 | 14.66 | 14.75 | 14.29 | 14.30 | 772.60K |
| Oct 12, 2026 | 14.54 | 14.76 | 14.26 | 14.72 | 782.00K |
| Oct 9, 2026 | 14.17 | 14.78 | 14.14 | 14.58 | 1.02M |
| Oct 8, 2026 | 14.59 | 14.59 | 13.82 | 14.22 | 2.96M |
| Oct 7, 2026 | 14.84 | 15.12 | 14.59 | 14.66 | 3.51M |
| Oct 6, 2026 | 15.27 | 15.88 | 14.90 | 14.97 | 1.76M |
| Oct 5, 2026 | 14.82 | 15.30 | 14.56 | 15.20 | 1.78M |
| Oct 2, 2026 | 16.24 | 16.24 | 14.91 | 14.94 | 1.70M |
| Oct 1, 2026 | 15.81 | 16.44 | 15.77 | 15.92 | 1.21M |
| Sep 30, 2026 | 16.01 | 16.09 | 15.73 | 15.95 | 1.88M |
| Sep 29, 2026 | 15.87 | 16.07 | 15.64 | 15.99 | 728.50K |
| Sep 28, 2026 | 15.68 | 15.90 | 15.20 | 15.83 | 896.00K |
| Sep 25, 2026 | 16.20 | 16.27 | 15.82 | 15.84 | 1.03M |
| Sep 24, 2026 | 16.42 | 16.42 | 15.73 | 16.20 | 1.14M |
| Sep 23, 2026 | 16.53 | 16.75 | 15.97 | 16.25 | 777.70K |
| Sep 22, 2026 | 16.70 | 16.79 | 16.53 | 16.67 | 1.04M |
| Sep 21, 2026 | 16.87 | 16.87 | 16.37 | 16.53 | 633.50K |
About NovoCure
NovoCure (NVCR) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in ST. HELIER. Fiscal year ends December 31. SEC CIK 1645113.
NVCR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| William F Doyle | Executive Chairman | Mar 5, 2026 |
| Asaf Danziger | Director | Jul 1, 2026 |
| Jeryl L Hilleman | Director | Jun 5, 2026 |
| David Hung | Director | Jun 5, 2026 |
| Gabriel Leung | Director | Jun 5, 2026 |
| Martin J. Madden | Director | Jun 5, 2026 |
| Allyson J Ocean | Director | Jun 5, 2026 |
| Timothy J Scannell | Director | Jun 5, 2026 |
| Kristin Stafford | Director | Jun 5, 2026 |
| W Anthony Vernon | Director | Jun 5, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Arye Barak Ben | General Counsel | Jul 1, 2026 |
| Christoph Brackmann | Chief Financial Officer | Mar 5, 2026 |
| Ashley Cordova | Former Chief Executive Officer | Mar 5, 2026 |
| William F Doyle | Executive Chairman | Mar 5, 2026 |
| Frank X Leonard | Chief Executive Officer | Jul 1, 2026 |
| Nicolas Leupin | Former Chief Medical Officer | Mar 5, 2026 |
| Mukund Paravasthu | Chief Operating Officer | Mar 5, 2026 |
| Michal Nath Puri | Chief Human Resources Officer | Jul 1, 2026 |
| Uri Weinberg | Chf Medical and Innovation Ofr | Mar 5, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 4, 2026 | Frank X Leonard | Sale | 34,273 | $17.93 |
| Jun 4, 2026 | Frank X Leonard | Sale | 34,273 | $17.93 |
| Jun 4, 2026 | Frank X Leonard | Sale | 34,273 | $17.93 |
| Jun 4, 2026 | Frank X Leonard | Sale | 34,273 | $17.93 |
| Jun 2, 2026 | Jeryl L Hilleman | Sale | 2,945 | $15.77 |
| Jun 2, 2026 | Jeryl L Hilleman | Sale | 2,945 | $15.77 |
| Jun 2, 2026 | Jeryl L Hilleman | Sale | 2,945 | $15.77 |
| Jun 2, 2026 | Jeryl L Hilleman | Sale | 2,945 | $15.77 |
| Jun 2, 2026 | Timothy J Scannell | Sale | 2,945 | $15.77 |
| Jun 2, 2026 | Timothy J Scannell | Sale | 2,945 | $15.77 |
| Jun 2, 2026 | Timothy J Scannell | Sale | 2,945 | $15.77 |
| Jun 2, 2026 | Timothy J Scannell | Sale | 2,945 | $15.77 |
| Jun 2, 2026 | Gabriel Leung | Sale | 2,945 | $15.77 |
| Jun 2, 2026 | Gabriel Leung | Sale | 2,945 | $15.77 |
| Jun 2, 2026 | Gabriel Leung | Sale | 2,945 | $15.77 |
NVCR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $655.35M | $-136.23M | -1.22 | $-49.03M |
| Dec 31, 2024 | $605.22M | $-168.63M | -1.56 | $-26.37M |
| Dec 31, 2023 | $509.34M | $-207.04M | -1.95 | $-73.34M |
| Dec 31, 2022 | $537.84M | $-92.53M | -0.88 | $30.79M |
| Dec 31, 2021 | $535.03M | $-58.35M | -0.56 | $82.76M |
Latest balance sheet: total assets $795.19M, total liabilities $457.10M, cash $93.70M (as of Jun 30, 2026).
NVCR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 23, 2026 | 8-K Item 2.02 (results) | $19.99 |
| Apr 30, 2026 | 8-K Item 2.02 (results) | $15.21 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $13.75 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $14.18 |
| Oct 30, 2025 | 8-K Item 2.02 (results) | $12.82 |
| Jul 24, 2025 | 8-K Item 2.02 (results) | $12.54 |
| Apr 24, 2025 | 8-K Item 2.02 (results) | $18.55 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $19.23 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $27.38 |
| Oct 30, 2024 | 8-K Item 2.02 (results) | $16.99 |
| Jul 25, 2024 | 8-K Item 2.02 (results) | — |
| May 2, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NVCR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.